Amedisys Inc. (AMED)

NASDAQ: AMED · Real-Time Price · USD

95.18

0.28 (0.30%)

At close: May 01, 2025, 3:38 PM

0.30% (1D)

Bid	n/a
Market Cap	3.12B
Revenue (ttm)	2.37B
Net Income (ttm)	114.39M
EPS (ttm)	2.71
PE Ratio (ttm)	35.12
Forward PE	18.28
Analyst	Hold

Ask	n/a
Volume	425,958
Avg. Volume (20D)	328,003
Open	95.00
Previous Close	94.90
Day's Range	94.75 - 95.57
52-Week Range	82.15 - 98.95
Beta	0.89

About AMED

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitatio...

[Read more]

Industry Medical - Care Facilities

Sector Healthcare

IPO Date Aug 17, 1994

Employees 19,000

Stock Exchange NASDAQ

Ticker Symbol AMED

Website https://www.amedisys.com

Full Company Profile

Analyst Forecast

According to 5 analyst ratings, the average rating for AMED stock is "Hold." The 12-month stock price forecast is $101, which is an increase of 6.11% from the latest price.

Stock Forecasts

Earnings Surprise

Amedisys has released their quartely earnings on Apr 23, 2025:

Revenue of $594.78M misses estimates by $1.51M, with 4.09% YoY growth.

EPS of 1.25 exceeds estimates by 0.14, with 21.36% YoY growth.

Why Price Moved

4 months ago

+4.67%

Amedisys shares are trading higher after the compa... Unlock content with Pro Subscription

News

6 days ago · zacks.com

AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise

Amedisys delivers first-quarter top-line growth across three of its segments, namely Home Health, Hospice and High Acuity Care.

1 week ago · zacks.com

Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street...

1 week ago · zacks.com

Amedisys (AMED) Tops Q1 Earnings Estimates

Amedisys (AMED) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $1.03 per share a year ago.

2 weeks ago · zacks.com

Amedisys (AMED) Earnings Expected to Grow: Should You Buy?

Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago · zacks.com

Why Is Amedisys (AMED) Up 1.3% Since Last Earnings Report?

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?

1 month ago · zacks.com

Here's Why You Should Retain AMED Stock in Your Portfolio Now

Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.

1 month ago · zacks.com

AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises

Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care.

2 months ago · zacks.com

Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compa...

2 months ago · zacks.com

Amedisys (AMED) Lags Q4 Earnings and Revenue Estimates

Amedisys (AMED) came out with quarterly earnings of $0.96 per share, missing the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $0.94 per share a year ago.